Biose is a startup founded in 1951 based in France. Brouky records 1 investor associated with the company.
Biose is a specialized contract development and manufacturing organization (CDMO) for Live Biotherapeutic Products (LBPs) and Next-Generation Probiotics (NGPs), providing end-to-end development, scale-up, and GMP manufacturing services for pharmaceutical and consumer-focused companies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.